Integra LifeSciences Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Integra LifeSciences (IART) Reports In-Line Q2 EPS; Tightens FY Rev Range
July 26, 2017 6:05 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.45, in-line with the analyst estimate of $0.45. Revenue for the quarter came in at $282.2 million versus the consensus estimate of $283.7 million.
The company is tightening full-year 2017 revenue guidance to a new range of $1.125 billion to $1.140 billion,... More